SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-017281
Filing Date
2023-05-15
Accepted
2023-05-15 16:06:03
Documents
49
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 598371
2 ex31-1.htm EX-31.1 18141
3 ex31-2.htm EX-31.2 18225
4 ex32-1.htm EX-32.1 7681
5 ex32-2.htm EX-32.2 7707
  Complete submission text file 0001493152-23-017281.txt   3581625

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE murf-20230331.xsd EX-101.SCH 28592
7 XBRL CALCULATION FILE murf-20230331_cal.xml EX-101.CAL 33894
8 XBRL DEFINITION FILE murf-20230331_def.xml EX-101.DEF 177743
9 XBRL LABEL FILE murf-20230331_lab.xml EX-101.LAB 238139
10 XBRL PRESENTATION FILE murf-20230331_pre.xml EX-101.PRE 207918
43 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 421431
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
Murphy Canyon Acquisition Corp. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41245 | Film No.: 23922060
SIC: 2834 Pharmaceutical Preparations